SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Felix B who wrote (2998)6/22/2020 9:38:10 AM
From: Biotechwantabe  Read Replies (1) | Respond to of 3557
 
30k/month treatment doses
360K/year
Price 15-25k. Guesstimate
5.4 - 9b.

Benchmark analyst estimate 50B for 2021. But not sure how he came to that. 2m doses/year

Obviously if they can increase production...

Dupixent round numbers
4m population
25k
100b tam
4% penetration current
4b
Sny target/goal 11b



To: Felix B who wrote (2998)6/22/2020 1:41:09 PM
From: Biotechwantabe  Respond to of 3557
 
Well that theory is no good. Otherwise buying wouldn’t have dried up.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News